Pipl - People Search

Volker Limmroth

 People Named Volker Limmroth : page 1 of 1

Volker Limmroth
University Of Essen...
Pages related to People Named Volker Limmroth:
migraine,paper,patients,MX,treatment,Limmroth,placebo,headache,multiple sclerosis,efficacy,fatigue,therapy,pain patient,neurology departments,three times daily,pain,City Hospitals,Diener,acute migraine,prevalence BioInfoBank Library ... [My paper] Simon Harnier, Andreas Harzheim, Volker Limmroth, Reinhold Horz, Jens Kuhn ... Eva Havrdova, Volker Limmroth, Chris H Polman, ... [ lib.bioinfo.pl ]
interferon,MD, PhD,patients,regard to,VOLKER,LIMMROTH,disability,BLITZ,SHABBIR,interferon treatment,treatment,The Treatment,preparations,relapse rate,EDSS,Quality Assessment,Multiple Sclerosis,disease progression,head-to-head,evidence VOLKER LIMMROTH, MD, PhD: QUASIMS stands for Quality Assessment ... VOLKER LIMMROTH, MD, PhD: The data of QUASIMS represent 510. sites and more than 4,700 patients. ... [ www.msleaders.com ]
overuse,Medication,CiteULike,MOH,worldwide problem,headache disorders,drugs,treatment,doses,disorder,reviews,bibliography manager,organising,library,Hans-Christoph Diener,Volker,The Lancet,Lancet Neurology,Vol. 3,No. 8 CiteULike is a free online bibliography manager. ... Medication-overuse headache: a worldwide problem. by: Hans-Christoph Diener, Volker Limmroth ... [ www.citeulike.org ]
Postgraduate Institute,Medicine,multiple sclerosis,neurology,Limmroth,Biogen Idec,Greenstein,Evaluation Form,participants,the New York,University Hospital,University of Essen,educational activity,interferons,IFN,preparations,residency,Volker,Healthology,Disclosure Statements Volker Limmroth, MD ... Volker Limmroth, MD, is an associate professor and vice chairman of the ... Volker Limmroth, MD: Honorarium: Biogen Idec. Jeffrey ... [ www.msleaders.com ]
patients,paper,migraine,CSF,MOH,polymorphism,cytology,flow cytometry,migraine prevention,headache,migraine patients,migraine attacks,unrelated patients,hypocretin,CPA,hepatotoxic,involvement,cell numbers,cluster headache,headache drugs BioInfoBank Library ... [My paper] Markus Schürks, Volker Limmroth, Ingrid Geissler, Grietje Tessmann, ... Savidou, Hans-Christoph Diener, Volker Limmroth ... [ lib.bioinfo.pl ]
ATL,treatment,antisense drug,Antisense,VLA-4,drugs,Isis Pharmaceuticals, Inc,multiple sclerosis,forward-looking statements,placebo,second-generation,MRI,reduction,target,MS patients,Ibis,human therapeutics,Trial Results,World Congress,ANP ... Investigator for the trial, Volker Limmroth, M.D., Ph.D., Chairman of the ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ ir.isispharm.com ]
TNF,patients,Rheumatology,Limmroth,rheumatoid arthritis,agents,PubMed,T2-weighted MRI,intermediate uveitis,Wanke,CNS disorders,Google Scholar,Social Bookmarking,therapy,Oxford Journals,RA,chronic inflammatory disorder,Oxford University Press,VIGNETTE,Thimm Email this article to a friend. Similar articles in this journal. Similar articles in PubMed ... E-mail: Volker.Limmroth{at}uni-essen.de ... [ rheumatology.oxfo...urnals.org ]
ATL,treatment,Multiple Sclerosis,patients,antisense drug,VLA-4,Antisense,drugs,Isis Pharmaceuticals, Inc,Phase IIa,placebo,second-generation,forward-looking statements,ANP,MRI,reduction,target,Ibis,Trial Results,Research Antisense Therapeutics Ltd. (ASX: ANP) and Isis Pharmaceuticals, Inc. ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ www.medicalnewstoday.com ]
ATL,treatment,antisense drug,VLA-4,Antisense,drugs,multiple sclerosis,forward-looking statements,Isis Pharmaceuticals, Inc,placebo,second-generation,MRI,reduction,target,MS patients,Ibis,human therapeutics,Trial Results,World Congress,Research ... Investigator for the trial, Volker Limmroth, M.D., Ph.D., Chairman of the ... MS Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) (1) Department of ... [ www.prnewswire.com ]
ATL,treatment,antisense drug,VLA-4,Antisense,drugs,Therapeutics,Multiple Sclerosis,forward-looking statements,Isis Pharmaceuticals, Inc,placebo,second-generation,Trial Results,World Congress,Research,MS patients,MRI,reduction,Ibis,Top Searches ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ www.genengnews.com ]
ATL,treatment,antisense drug,Antisense,VLA-4,drugs,multiple sclerosis,Isis Pharmaceuticals, Inc,forward-looking statements,placebo,second-generation,Research,Ibis,MRI,reduction,target,MS patients,human therapeutics,Trial Results,World Congress ... Investigator for the trial, Volker Limmroth, M.D., Ph.D., Chairman of the ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ www.istockanalyst.com ]
patients,multiple sclerosis,two years,MS Therapy,therapy,mcg,Avonex,Investigators,Docs,interferon beta-1a,Neighborhood,long term,Limmroth,interferon-beta,interferon,relapse-free,preparations,findings,John C. Martin,annual meeting Investigators taking part in the largest retrospective, observational study of ... Volker Limmroth, MD, PhD, in the department of Neurology at University Hospital ... [ www.msneighborhood.com ]
migraine,receptors,CGRP,Neurological Disorders,Drug Targets,glutamate receptors,pathophysiology,Drugs,the Treatment,Chinese herbs,herbal extracts,agonists,antipsychotic drugs,Epilepsy,5-HT1B,targets,mechanisms,statins,tension-type headache,cortical spreading depression The new journal for expert reviews on drug targets for CNS & neurological disorders. ... Anja Puppe and Volker Limmroth [Abstract] ... Anja Puppe and Volker Limmroth ... [ www.bentham.org ]
The Lancet,Volker,Limmroth,headache,Search,overuse,Hans-Christoph Diener,drug-induced headache,chronic daily headache,efficacy,Medication,drugs,sumatriptan,Lancet Neurology,serotonin agonists,Journals,MOH,analgesics,treatment,frequencies The Lancet is the world's leading general medical journal and specialty journals ... Search results for Volker Limmroth in Authors ... [ www.thelancet.com ]
headache,medication,overuse,predictors,prospective study,Limmroth,patients,American Academy of Neurology,tension-type headache,University Hospital Essen,Essen, Germany,relapse rate,PubMed,Fritsche,migraine,Google Scholar,Address correspondence,Chronic Daily Headache,Collections,Brief Communications ... and reprint requests to Dr. Volker Limmroth, Department of Neurology, University ... 55, 45122 Essen, Germany; e-mail: volker.limmroth{at}uni-essen.de ... [ www.neurology.org ]
ATL,Antisense,antisense drug,treatment,VLA-4,drugs,Isis Pharmaceuticals, Inc,NewsWire,multiple sclerosis,forward-looking statements,placebo,second-generation,MRI,reduction,target,MS patients,Ibis,human therapeutics,Trial Results,World Congress ... Investigator for the trial, Volker Limmroth, M.D., Ph.D., Chairman of the ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ www.globeinvestor.com ]
ATL,treatment,Antisense,antisense drug,VLA-4,drugs,Multiple Sclerosis,Therapeutics,Online Store,placebo,second-generation,Trial Results,Phase IIa,Isis Pharmaceuticals, Inc,MS patients,MRI,reduction,target,World Congress,Research PipelineReview.com is the Biotech News Center and Online Store of La Merie Business Intelligence ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ www.pipelinereview.com ]
migraine,adrenoceptor,blockers,propranolol,migraine prophylaxis,prophylactic treatment,Headache,drugs,prophylactic,placebo,metoprolol,flunarizine,efficacy,calcium entry blockers,Clinical trials,migraine attacks,migraine treatment,agents,prophylactic efficacy,trials Journal List > Br J Clin Pharmacol > v.52(3); Sep 2001. Abstract. Full Text. PDF (83K) ... Volker Limmroth and Martin C Michel ... [ www.pubmedcentral.nih.gov ]
withdrawal headache,patients,overuse,triptans,headache,Limmroth,headache drugs,Clinical features,Fritsche,Diener,analgesics,American Academy of Neurology,migraine,medication,ergots,headache medication,overused,duration,Muessig,University Hospital Essen Alert me when this article is cited. Alert me when Correspondence are posted ... 55, 45122 Essen, Germany; e-mail: volker.limmroth{at}uni-essen.de ... [ www.neurology.org ]
Mitoxantrone,regulatory T cells,Tregs,suppression,MBP,suppressive activity,Fails,CD4,CD25,MS patients,PWM,Diseases,Multiple Sclerosis,autoimmunity,treatment,Sclerosis Patients,P01,Manoj Kumar,Erich,Volker Norman Putzki, Manoj Kumar, Erich Kreutzfelder, Volker Limmroth, Essen, Germany ... We recently demonstrated that the suppressive function of Treg is impaired in MS ... [ www.abstracts2view.com ]
CNS disease,disease management,patients,Neura,central nervous system,cumulative number,lesions,Therapies,Perspectives,mRNA sequences,treatment,amyotrophic lateral sclerosis,BioScience,nervous system disease,central nervous system diseases,Text Size,mental health,Proof-of-Concept Study,Antisense Oligonucleotide,Antisense oligonucleotides Home > Congress Coverage > WCTRIMS 2008 > Examining Emerging Therapies & Approaches ... results were reported by Volker Limmroth, University of Cologne, Cologne, ... [ www.neura.net ]
GRK2,mice,EAE,WT,cells,patients,animals,T cells,expression,RR,receptor,PBMC,levels,kinase,CNS,MS patients,disease,chemokines,GPCR,activated Anne Vroon,* Annemieke Kavelaars,* Volker Limmroth, Maria Stella Lombardi,* Marion U. Goebel, ... Many modulators of inflammation, including chemokines, ... [ www.jimmunol.org ]
ATL,treatment,Antisense,antisense drug,drugs,VLA-4,Isis Pharmaceuticals, Inc,Multiple Sclerosis,forward-looking statements,placebo,second-generation,human therapeutics,Phase IIa,MS patients,Trial Results,World Congress,Research,ANP,MRI,reduction MELBOURNE, Australia and CARLSBAD, Calif., Sept. 22 -- Antisense Therapeutics ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ www.earthtimes.org ]
No Differences,Interferon Beta,Beta Products,bugs,L Consulting,Consulting Group Inc,docguide,News Story,Story Page MIAMI, FL -- April 22, 2005 -- Researchers investigating different interferon ... Lead author Volker Limmroth, MD, associate professor and vice chairman, ... [ www.docguide.com ]
beta products,interferon beta,patients,No Differences,Interferon beta-1a,mcg,Doctor's Guide,multiple sclerosis,efficacy,Limmroth,Brazil,Benelux,Italy,Slovakia,treatment,Bookstore,Congresses,Unregistered,Medline,Ed Susman Click here to choose your favourite journals. Favourite Sites ... Lead author Volker Limmroth, MD, associate professor and vice chairman, ... [ www.docguide.com ]
ATL,treatment,VLA-4,antisense drug,Antisense,drugs,multiple sclerosis,forward-looking statements,placebo,second-generation,Isis Pharmaceuticals, Inc,MRI,reduction,target,MS patients,Ibis,azcentral,business news,ANP,Phase IIa Follow breaking national and world business news on azcentral.com. ... MS Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) (1) Department of ... [ www.prnewswire.com ]
NPY,indomethacin,Neuropeptide,Anesthetized,Bischoff,Natriuretic,rats,Treatment,systemic,PubMed,urine,sodium excretion,cyclooxygenase,mm Hg,diuresis,natriuresis,Google Scholar,C. Michel,Angela,Volker Alert me when eLetters are posted. Alert me if a correction is posted. Citation Map ... Angela Bischoff, Volker Limmroth and Martin C. Michel ... [ jpet.aspetjournals.org ]
patients,interferon beta,treatment,Avonex,multiple sclerosis,neutralizing antibodies,mitoxantrone,mcg,Betaseron,agents,therapy,MS patients,antibodies,Pachner,EDSS,European Neurological Society,sclerosis patients,titers,Barcelona, Spain,baseline Millennium CME Institute is a leading independent provider of continuing medical ... Volker Limmroth, MD, PhD, University Hospital Essen, Essen, Germany ... [ www.millennium-cme.com ]
Cisplatin,mice,Recombinant Erythropoietin,the Level,DNA-adducts,group A,peripheral neuropathy,DNA Adducts,treatment,platinum,neurotoxic,side-effects,neuroprotective effect,nerve conduction velocity,polyneuropathy,withdrawal,thresholds,mechanical sensitivity,adduct,Peripheral Nerve Min-Suk Yoon, Zaza Katsarava, Anna Dzagnidze, Essen, NRW, Germany, Maria ... Egensperger, Andreas Kribben, Volker Limmroth, Hans-Christopher Diener, Jürgen ... [ www.abstracts2view.com ]
ATL,Teva,ANP,Multiple Sclerosis,reduction,Novel Drug,Antisense,a Novel,the Treatment,disease activity,lesions,Top Searches,Biotechnology,Teva Pharmaceutical Industries Ltd,MS patients,antisense drug,VLA-4,Ph.D,bioindustry,RRMS Teva & ANP Announce That ATL/TV1102, a Novel Drug for the Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) ... the trial, Volker Limmroth MD PhD, ... [ www.genengnews.com ]
ANP,treatment,ATL,Antisense,antisense drug,Therapeutics,Teva,disease,acromegaly,diabetic retinopathy,IGF-I levels,prostate cancer,blood,Online Store,Multiple Sclerosis,toxicology studies,target,second generation,IGF-IR,GH PipelineReview.com is the Biotech News Center and Online Store of La Merie Business Intelligence focused on Research ... the trial, Volker Limmroth MD PhD, ... [ www.pipelinereview.com ]
GRK2,Kinase,Multiple Sclerosis,Kavelaars,G Protein-Coupled Receptor,Experimental Autoimmune Encephalomyelitis,Vroon,EAE,mice,G-Protein-Coupled Receptor Kinase,GPCR,patients,cells,onset,T cells,macrophages,animals,JI,PubMed,Laboratory Copyright © 2005 by The American Association of Immunologists ... Vroon*, Annemieke Kavelaars*, Volker Limmroth, Maria Stella Lombardi*, Marion ... [ www.jimmunol.org ]
Bernd,Liedert,drug cisplatin,DNA,Onkologie,Substanzen,Cis,Carboplatin,Zytostatika,Tumoren,Mechanismen,Commons,anticancer drug,cytotoxic activity,crosslinks,relative contribution,Publication List,Co-Authors,DNA adducts,neurotoxicity Volker Limmroth (1) Repair capacity for Platinum-DNA adducts determines the severity of cisplatin ... Dzagnidze, Anna, Katsarava, Zaza, Makhalova, Julia, ... [ en.scientificcommons.org ]
Knowledge Express,technology transfer,biotechnology,company,Phase IIa,MRI,competitive intelligence,pharmaceutical market,Free eMarket,drug candidate,clinical trial,MS patients,disease,intervals,Professor,Limmroth,treatment,UTEK,company profiles,university technologies Online databases for business development, licensable technologies, biotechnology, ... of the Phase IIa trial, Professor Volker Limmroth from the University of ... [ www.knowledgeexpress.com ]
ATL,Teva,ANP,Antisense,treatment,reduction,Teva Pharmaceutical Industries Ltd,antisense drug,Novel Drug,The Treatment,Multiple Sclerosis,Pharmacist,a Novel,disease activity,Therapeutics,Phase IIa,lesions,MS patients,drug,VLA-4 Results Demonstrate Impressive Reduction of Disease Activity ... Principal Investigator for the trial, Volker Limmroth MD PhD, Chairman of the ... [ www.pharmacistelink.com ]
ATL,Teva,ANP,Teva Pharmaceutical Industries Ltd,Antisense,treatment,antisense drug,reduction,drugs,Multiple Sclerosis,disease activity,Therapeutics,Phase IIa,lesions,MS patients,Novel Drug,the Treatment,VLA-4,forward-looking statements,a Novel -- Results Demonstrate Impressive Reduction of Disease Activity as Early as 8 Weeks - -- Teva Intends to Conduct ... the trial, Volker Limmroth MD PhD, ... [ www.foxbusiness.com ]
ATL,Teva,ANP,treatment,Antisense,reduction,Teva Pharmaceutical Industries Ltd,antisense drug,Multiple Sclerosis,disease activity,Therapeutics,Phase IIa,lesions,MS patients,Novel Drug,the Treatment,drug,VLA-4,forward-looking statements,a Novel Small Cap Gains: 2 IPOs The Entire Market Should Be Watching ... Principal Investigator for the trial, Volker Limmroth MD PhD, Chairman of the ... [ www.istockanalyst.com ]
Drug Safety,Volume 24,Search,Marco De Santis,TABLE OF CONTENTS,Leading Article,Post-Marketing Surveillance,Vigilance,Medical Devices,European Approach,Hepatotoxicity,Thiazolidinediones,Class Effect,Scheen,Drug-Induced,Congenital Defects,Strategies,Incidence,Brigida,Carducci Drug-Induced Congenital Defects: Strategies to Reduce the Incidence. ... Zaza Katsarava; Hans-Christoph Diener; Volker Limmroth. Abstract. HTML. PDF (236 K) ... [ pt.wkhealth.com ]
Drug Delivery,American Journal,Volume 2,Issue 1,Therapy,Adis,Spotlight,Search,Emerging Technology,Healthcare Technology,TABLE OF CONTENTS,Closed-Loop,Insulin,Diabetes Mellitus,Joan Taylor,Sangeeta,Tanna,Tarsem,Sahota,Sanjay Garg Factors Affecting Mechanism and Kinetics of Drug Release from Matrix-Based Oral ... Volker Limmroth; Andrew J Dowson; Hans-Christoph Diener; Carl Dahlöf ... [ pt.wkhealth.com ]
ATL,Teva,ANP,reduction,Antisense,treatment,Novel Drug,the Treatment,Multiple Sclerosis,Teva Pharmaceutical Industries Ltd,a Novel,antisense drug,Disease Activity,Therapeutics,Phase IIa,lesions,RRMS,MS patients,Thomson,drug Teva & ANP Announce That ATL/TV1102, a Novel Drug for the Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) ... the trial, Volker Limmroth MD PhD, ... [ www.reuters.com ]
Antisense,Therapeutics,Rodman & Renshaw,10th Annual,ATL,Healthcare Conference,antisense drug,second-generation,prostate cancer,ASX,antisense inhibitor,Company,pre-clinical research,ANP,Phase IIa,MELBOURNE, AUSTRALIA,MARKET WIRE,MS treatment,research study,research stage Antisense Therapeutics to Present at Rodman & Renshaw 10th Annual Healthcare ... for the trial, Volker Limmroth, M.D., Ph.D., Chairman of the Department of ... [ biz.yahoo.com ]
ATL,treatment,VLA-4,antisense drug,Antisense,Multiple Sclerosis,drugs,World Congress,Trial Results,Research,forward-looking statements,placebo,second-generation,Isis Pharmaceuticals, Inc,MRI,reduction,target,MS patients,Ibis,Washington DC ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ www.examiner.com ]
National MS Society,treatment,lesions,World Congress,therapies,placebo,multiple sclerosis,disease,cognitive impairment,clinical trials,Fampridine,central nervous system,MRI,new formula,investigators,quality of life,intracortical,text size,walking speed,consistent improvement MS stops people from moving. The National MS Society exists to make sure ... The study, presented by Volker Limmroth, MD, PhD (University of Cologne, Germany) ... [ www.nationalmssociety.org ]
Antisense,Therapeutics,Rodman & Renshaw,ATL,10th Annual,antisense drug,Healthcare Conference,ANP,Thomson,second-generation,prostate cancer,Reuters journalists,MARKET WIRE,ASX,antisense inhibitor,pre-clinical research,MELBOURNE, AUSTRALIA,Phase IIa,today announced,Global Healthcare Conference MELBOURNE, AUSTRALIA, Oct 27 (MARKET WIRE) -- Antisense Therapeutics Limited (ASX: ANP) today announced that the ... the trial, Volker Limmroth, M.D., Ph. ... [ www.reuters.com ]
ATL,treatment,antisense drug,VLA-4,Antisense,drugs,multiple sclerosis,Test Release,forward-looking statements,Isis Pharmaceuticals, Inc,placebo,second-generation,MRI,reduction,target,MS patients,Ibis,Phase IIa,human therapeutics,ANP ... Investigator for the trial, Volker Limmroth, M.D., Ph.D., Chairman of the ... Volker Limmroth(1), Frederik Barkhof(2), Nuket Desem(3) ... [ www.upi.com ]
World Congress,treatment,lesions,MS Center,multiple sclerosis,therapies,placebo,Late-Breaking News,Rehabilitation Strategies,disease,cognitive impairment,research,clinical trials,Stony Brook University Hospital,Fampridine,central nervous system,MRI,new formula,investigators,quality of life The Pediatric MS Center is a unique multidisciplinary clinical and research program within one of the leading research ... by Volker Limmroth, MD, PhD ... [ www.pediatricmscenter.org ]
Drug Targets,Neurological Disorders,IngentaConnect,CNS disorders,Ingenta,Table Of Contents,Free Content,Free Trial,German Sierra,receptors,Migraine,report problems,Researchers,Librarians,aims,developments,medicinal chemistry,pharmacology,molecular biology,genomics CNS & Neurological Disorders - Drug Targets aims to cover all ... Authors: Anja Puppe,; Volker Limmroth, The Role of Glutamate and its Receptors in Migraine ... [ www.ingentaconnect.com ]
migraine,headache,migraine prophylaxis,Prophylactic drugs,refractory,targets,prophylactic treatment,Tfelt-Hansen,headache patients,prophylactic,Frese,Sonja,preventive treatment,Jes Olesen,clinical trials methodology,drugs,mechanisms,neurologists,Peer,efficacy Customers in the UK and Europe: special time-limited offer on this title ... and amine agonists: efficacy , Hans-Christoph Diener and Volker Limmroth ... [ www.oup.com ]
DNA Adducts,Juergen,Thomale,Repair Capacity,drug cisplatin,Severity,PubMed,neuronal cells,Essen, Germany,Medical School,dorsal root ganglion,Search,Cancer Research,DNA adduct,DNA repair,Peripheral,PLATINUM COMPOUNDS,Correspondence,addressed,Institute Email this article to a friend. Similar articles in this journal ... Liedert,1 Min-Suk Yoon,2 Holger Kaube,3,4 Volker Limmroth,2 and Juergen Thomale1 ... [ www.jneurosci.org ]
maleate,fumarate hydratase,mice,genes,FH,CO2,Treatment,search,search result,relevance,patients,Cancer cell,toluene,germline,reaction,tumors,VNO,C2H2,H2O,scientists You must enable JavaScript to run the NextBio application. Treatment 2 ... David G Macmanus, Eva Havrdova, Volker Limmroth, Chris H Polman, Klaus Schmierer, ... [ www.nextbio.com ]
Terms  Privacy  Directory  Contact
©2006-2009 Pipl